本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artelo Biosciences, Inc.

4.85
-0.9400-16.23%
盘前3.40-1.4499-29.89%08:17 EDT
成交量:331.35万
成交额:1,999.79万
市值:1,153.18万
市盈率:-0.13
高:5.78
开:4.85
低:4.24
收:5.79
52周最高:85.80
52周最低:3.15
股本:237.77万
流通股本:233.15万
量比:0.23
换手率:142.12%
股息:- -
股息率:- -
每股收益(TTM):-37.5600
每股收益(LYR):-54.8768
净资产收益率:-1625.11%
总资产收益率:-190.09%
市净率:-9.07
市盈率(LYR):-0.09

数据加载中...

2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/12

SEC问询函

Form CORRESP - Correspondence
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/21

重要事件披露

8-K - Current report
2023/04/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report